1 not yet recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Lipidomics: new trials by email Literature Review of Lipidomics trials Research Report on Lipidomics
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Semaglutide Treatment in Type 1 Diabetes Semaglutide 2.4mg, Semaglutide placebo - Obesity in Diabetes, Obesity/Therapy | Phase 3 | Not yet recruiting | Nordsjaellands Hospital | 122 | 2025-10-01 | 2025-08-08 |
Diabetes Mellitus, Type 1 (1) · Insulin Resistance (1) · Obesity (1) · Weight Loss (1)
Autoimmune Diseases (1) · Body Weight (1) · Body Weight Changes (1) · Diabetes Mellitus (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Hyperinsulinism (1) · Immune System Diseases (1) · Metabolic Diseases (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Overnutrition (1) · Overweight (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
semaglutide (1)
Denmark (1)